| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in decreased expression of CBX1 mRNA | decreases expression | 16514628
|
| C040534 |
alpha-hexachlorocyclohexane |
alpha-hexachlorocyclohexane results in decreased expression of CBX1 mRNA | decreases expression | 16940010
|
| D003513 |
Cycloheximide |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of CBX1 mRNA | affects cotreatment|increases expression | 19684285
|
| D004958 |
Estradiol |
Estradiol results in decreased expression of CBX1 mRNA | decreases expression | 15757668
|
| D004958 |
Estradiol |
Estradiol results in increased expression of CBX1 mRNA | increases expression | 16514628
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of CBX1 mRNA | decreases expression | 17475347
|
| D005472 |
Fluorouracil |
CBX1 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
| C070081 |
fulvestrant |
fulvestrant results in decreased expression of CBX1 mRNA | decreases expression | 16514628
|
| C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CBX1 mRNA | decreases expression | 18445702
|
| D020849 |
Raloxifene |
Raloxifene results in decreased expression of CBX1 mRNA | decreases expression | 16514628
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of CBX1 mRNA | affects cotreatment|increases expression | 19684285
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CBX1 mRNA | increases expression | 19684285
|
| D014212 |
Tretinoin |
Tretinoin results in decreased expression of CBX1 protein | decreases expression | 16569592
|
| D014212 |
Tretinoin |
EHMT2 protein promotes the reaction [Tretinoin promotes the reaction [CBX1 protein binds to POU5F1 promoter]] | affects binding|increases reaction | 16415856
|
| D014212 |
Tretinoin |
EHMT2 protein promotes the reaction [Tretinoin promotes the reaction [CBX1 protein binds to ZFP42 promoter]] | affects binding|increases reaction | 16415856
|
| D014212 |
Tretinoin |
Tretinoin promotes the reaction [[HIST3H3 protein modified form binds to CBX1 protein] which binds to POU5F1 promoter] | affects binding|increases reaction | 16415856
|
| D014212 |
Tretinoin |
Tretinoin promotes the reaction [[HIST3H3 protein modified form binds to CBX1 protein] which binds to ZFP42 promoter] | affects binding|increases reaction | 16415856
|
| C025643 |
vinclozolin |
vinclozolin results in decreased expression of CBX1 mRNA | decreases expression | 18042343
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 11752688 14514962 15322242 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.21 | 11473722 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.21 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
7.21 | 17638652 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.42 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.42 | 16835633 |
| MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.72 | 17451421 17308373 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.70 | 15955085 |
| MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.56 | 15800139 |
| MESH:D000740 |
Anemia |
|
Fluorouracil |
9.03 | 17963324 15504547 16511603 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.03 | 11748828 |
| MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.73 | 19015723 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.42 | 15885639 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.42 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.29 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.37 | 16456186 |
| MESH:D001284 |
Atrophy |
|
fulvestrant |
4.97 | 11514358 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.53 | 16935849 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.93 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.93 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.93 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
| MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.61 | 16580743 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.01 | 12948864 17261762 17289903 16675129 17018787 14630087 19861407 18497071 |
| MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.01 | 16595493 16110121 18608205 18357371 19217205 16557594 15136595 |
| MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
3.01 | 18984771 |
| MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
3.01 | 17440819 17242785 15775269 15572757 17049068 17893378 17261762 16912660 16837676 15758505 17595753 17952589 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.01 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.01 | 16873071 16443354 16166294 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.74 | 16813970 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.62 | 16111702 |
| MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.84 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.48 | 17121937 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.48 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.33 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.71 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
4.71 | 18930000 16332177 17088986 16799960 17971768 17045692 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.71 | 1917145 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.06 | 18695887 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.82 | 18986760 16757204 17066447 16280240 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.82 | 16096774 16051514 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.17 | 17572228 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 16120746 18670907 18850075 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.52 | 15775269 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
3.15 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.84 | 18566989 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.74 | 16129372 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.01 | 17333356 16919318 11677210 16105132 17110522 17681005 15861022 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.01 | 19176532 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.33 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.90 | 12621046 15340226 15668235 8697196 16354765 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.90 | 9407595 |
| MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.76 | 15800139 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.84 | 17035595 |
| MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.25 | 17287894 17725105 17016597 16510598 17018589 15001691 17169374 16340194 18772588 17172411 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 17695437 17401013 16391804 14970324 16282729 18802399 18448328 18509181 18949393 15148649 18288408 16331619 17594712 20501625 15289873 18383874 17016601 17454858 16303861 16524972 17094418 17255274 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.48 | 10048152 20055451 15322242 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.48 | 17551590 9125849 10589399 9224671 16925845 8800419 14991402 9142499 9211117 9664655 |
| MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.47 | 14966744 |
| MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.95 | 16733453 |
| MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.26 | 17474826 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.34 | 19279558 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.34 | 15920148 17451421 17308373 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.56 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
12.08 | 12083418 |
| MESH:D004487 |
Edema |
|
Raloxifene |
12.08 | 15860553 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.08 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.53 | 18230668 15322242 16714409 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.53 | 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.54 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.54 | 15845917 |
| MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
12.98 | 19148513 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.98 | 19148513 18566989 11473722 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.98 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.47 | 16481741 16337965 17638652 16785472 15173087 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.11 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.11 | 16938888 9664655 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.76 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.76 | 20131406 19236843 |
| MESH:D005234 |
Fatty Liver |
|
Raloxifene |
13.76 | 17473493 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.09 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.09 | 17994277 |
| MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.09 | 16973722 |
| MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.47 | 16417039 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.07 | 17312396 |
| MESH:D005910 |
Glioma |
|
Fluorouracil |
2.91 | 16145905 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
8.03 | 18337622 15102660 15162350 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
8.03 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.33 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.72 | 11294989 10048152 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.72 | 9664655 14991402 |
| MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.61 | 11110106 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.73 | 16221962 19176532 18467677 19772884 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.73 | 15340226 16120746 12621046 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.21 | 15709030 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.93 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 8697196 16354765 15340226 18606429 16959395 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.30 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.71 | 16778211 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Raloxifene |
5.35 | 15787275 17577099 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.35 | 18670907 18850075 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.73 | 17937319 |
| MESH:D007248 |
Infertility, Male |
|
fulvestrant |
11.73 | 11514358 |
| MESH:D007248 |
Infertility, Male |
|
vinclozolin |
11.73 | 16467254 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12200463 12878042 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.43 | 16393666 16627594 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.43 | 16306350 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.90 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.30 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.30 | 15992940 17551590 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.64 | 15618244 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.79 | 15610895 |
| MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.79 | 16985049 |
| MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.61 | 16973256 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
2.82 | 17143497 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.81 | 16932348 19285840 16482212 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.09 | 19850784 17596541 16294345 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.22 | 19075265 17712046 19642359 17368321 17339181 16766008 17649720 9834237 17294898 16331271 17107899 16140955 16823087 17217047 16788101 15748426 19035177 17361223 17506722 19225113 16891316 19029980 16935935 12679006 17301526 |
| MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.89 | 16417039 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.38 | 9224671 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
5.02 | 14659978 14716833 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
5.02 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.02 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
5.02 | 16248980 18397230 |
| MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
7.59 | 15113037 17045692 16603448 18383874 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.59 | 16377806 20007298 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.59 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.17 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.37 | 15246190 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.37 | 11884234 19555203 |
| MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.95 | 15086387 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.62 | 17203775 11807958 16891317 11408345 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.66 | 19453300 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.82 | 17453147 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
1.95 | 16752155 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.56 | 16940565 |
| MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.73 | 15863610 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.71 | 18986760 16757204 |
| MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.51 | 16497877 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.14 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.53 | 16810080 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.53 | 16411023 |
| MESH:D009232 |
Myxoma |
|
Raloxifene |
5.73 | 16343187 |
| MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.55 | 18600527 16928823 18239605 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.55 | 17405874 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.55 | 16946489 16594593 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.89 | 17289903 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
17.10 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
17.10 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
17.10 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.12 | 9142499 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.51 | 16436463 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
| MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.46 | 17882678 15775268 19059307 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.34 | 15579764 17893378 15758505 17823083 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.91 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.91 | 16936753 |
| MESH:D010146 |
Pain |
|
Tretinoin |
2.99 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.46 | 16500647 16929163 15113037 19003803 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.46 | 15976015 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.01 | 11399792 11118676 11222880 11896295 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
10.01 | 18042343 18220299 19015723 |
| MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.09 | 18220299 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.99 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17199135 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.60 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.60 | 18626508 19082440 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.60 | 16220300 15731164 16536755 |
| MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.09 | 18629315 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.72 | 16636307 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 15861022 16919318 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.95 | 16723453 |
| MESH:D011693 |
Purpura |
|
Raloxifene |
5.73 | 15770314 |
| MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.11 | 15538739 18286688 16160472 18722050 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.22 | 16116481 16283617 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.72 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.72 | 16467112 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
| MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.53 | 17498489 19084572 16424979 19015929 17522103 17172411 18567086 16951190 18396642 15786421 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.53 | 17261132 |
| MESH:D020521 |
Stroke |
|
Raloxifene |
3.91 | 16837676 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.11 | 17045167 16026305 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
14.30 | 19048282 |
| MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
14.30 | 19048282 |
| MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
10.18 | 16280240 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
10.18 | 16051514 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.29 | 16040207 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
2.85 | 17572228 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.80 | 16803524 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.80 | 16129372 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.78 | 16752155 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
| MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.38 | 16837676 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.18 | 16761959 |
| MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.73 | 16343187 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.07 | 16287080 |